BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2738706)

  • 1. Preparation and evaluation of a 99mTc-SnF2 colloid kit for leukocyte labeling.
    Hirsch JI; Tatum JL; Fratkin MJ; Apostolides DL; Quint RI
    J Nucl Med; 1989 Jul; 30(7):1257-63. PubMed ID: 2738706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of canine leukocytes radiolabeled in whole blood with (99m)Tc stannous colloid.
    Abushhiwa MH; Salehi NS; Whitton RC; Charles JA; Finnin PJ; Lording PM; Caple IW; Parry BW
    Nucl Med Biol; 2008 Aug; 35(6):707-12. PubMed ID: 18678356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m leucocyte labelling using a lyophilised stannous fluoride colloid kit.
    Martindale AA; Peris MJ; Turner JH; Robertson T; Papadimitriou JM
    Prog Clin Biol Res; 1990; 355():257-60. PubMed ID: 2281105
    [No Abstract]   [Full Text] [Related]  

  • 5. [Labeling of leukocytes using stannous 99mTc-colloid in whole blood samples].
    Rabiller G; Questa L; Galli R; Viscusi F; El Tamer E
    Rev Esp Med Nucl; 2004; 23(1):22-6. PubMed ID: 14718147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of abdominal infection using 99m Tc stannous fluoride colloid labelled leukocytes.
    Carter NJ; Eustance CN; Barrington SF; O'Doherty MJ; Coakley AJ
    Nucl Med Commun; 2002 Feb; 23(2):153-60. PubMed ID: 11891469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiopharmaceutical chemistry of 99mTc-tin fluoride colloid-labeled-leukocytes.
    Tsopelas C
    Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):319-24. PubMed ID: 16407815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-SnF2 colloid "LLK": particle size, morphology and leucocyte labelling behaviour.
    McClelland CM; Onuegbulem E; Carter NJ; Leahy M; O'Doherty MJ; Pooley FD; O'Doherty T; Newsam RJ; Ensing GJ; Blower PJ
    Nucl Med Commun; 2003 Feb; 24(2):191-202. PubMed ID: 12548044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m labeled leukocytes: preparation and use in identification of abscess and tissue rejection.
    Farid NA; White SM; Heck LL; Van Hove ED
    Radiology; 1983 Sep; 148(3):827-31. PubMed ID: 6308712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of feline leukocytes radiolabeled in whole blood with 99mTc stannous colloid.
    Abushhiwa MH; Salehi NS; Whitton RC; Charles JA; Finnin PJ; Lording PM; Parry BW
    Vet Radiol Ultrasound; 2009; 50(5):545-9. PubMed ID: 19788042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
    Hung JC; Chowdhury S; Mullan BP
    J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m white cell scintigraphy in suspected acute infection.
    Southee AE; Lee KJ; McLaughlin AF; Borham PW; Bautovich GJ; Morris JG
    Clin Nucl Med; 1990 Feb; 15(2):71-5. PubMed ID: 2311327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of occult phlebitis with Tc-99m stannous fluoride colloid labeled white blood cell scintigraphy.
    Chan KW; Stewart IE; Metreweli C
    Clin Nucl Med; 1995 Jul; 20(7):645-6. PubMed ID: 7554677
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory lesions localized with technetium Tc 99m-labeled leukocytes.
    Andersen BR; English D; Akalin HE; Henderson W
    Arch Intern Med; 1975 Aug; 135(8):1067-71. PubMed ID: 1156068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Localization diagnosis and differential diagnosis of postoperative intraperitoneal abscesses using 99m technetium-stannum-colloid-marked granulocytes].
    Koch B; Wolf N; Schwaiger C; Farthmann EH; Schroth HJ; Berberich R; Wilhelm H; Oberhausen E
    Chirurg; 1982 Mar; 53(3):149-53. PubMed ID: 7067536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
    Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
    J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
    Kelbaek H; Fogh J
    J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo kinetics of canine leukocytes labeled with technetium-99m HM-PAO and indium-111 tropolonate.
    Mock BH; Schauwecker DS; English D; Young KA; Wellman HN
    J Nucl Med; 1988 Jul; 29(7):1246-51. PubMed ID: 3392583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of indium-111-2-mercaptopyridine-N-oxide for labeling leukocytes in plasma: a kit preparation.
    Thakur ML; McKenney SL; Park CH
    J Nucl Med; 1985 May; 26(5):518-23. PubMed ID: 3857295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.